Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
基本信息
- 批准号:8259782
- 负责人:
- 金额:$ 35.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:Angiogenic FactorAreaBlood VesselsCancer EtiologyCardiovascular DiseasesCell Cycle ProgressionCell ProliferationCell physiologyCellsComplementComplexCoronary RestenosisCytomegalovirusCytomegalovirus InfectionsDNA biosynthesisDeoxyribonucleosidesDiseaseEndothelial CellsEnzymesFamilyFibroblastsGene ExpressionGenesGenetic TranscriptionGoalsHealthHerpesviridaeLytic PhaseMalignant GliomaMediatingNewborn InfantNucleotidesPathogenesisPathologyPathway interactionsPharmaceutical PreparationsPhenotypePlayPrincipal InvestigatorProcessProtein BindingProtein KinaseProteinsResearch DesignRetinoblastomaRetinoblastoma ProteinRoleSclerosisSmooth Muscle MyocytesTransplant RecipientsTransplantationViralViral PathogenesisVirusWound Healingangiogenesiscancer therapycancer typecell growthcofactormembermetaplastic cell transformationpathogenprogramsrestenosisretinoblastoma tumor suppressortherapy designtranscription factorviral DNA
项目摘要
DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) is a ubiquitous and significant pathogen that stimulates cell cycle progression. HCMV is a cofactor for cardiovascular diseases with significant proliferative components such as coronary restenosis and transplant vascular sclerosis (TVS), and may play a role in certain types of cancers, most notably, malignant gliomas (GBMs). Cellular proliferation and transformation is regulated by the retinoblastoma family of tumor suppressors (Rb, p107, and p130). The Rb proteins, in conjunction with the E2F family of transcription factors, regulate the expression of cellular genes required for DNA replication such as nucleotide biosynthetic enzymes (NBEs) of the de novo pathway, as well as secreted factors involved in wound healing and angiogenesis. The expression of E2F-responsive genes is inhibited when the hypophosphorylated forms of the Rb proteins are bound to the E2F proteins. Degradation of the hypophosphorylated Rb proteins, or their hyperphosphorylation disrupts their complexes with E2F, thus allowing free E2F to activate gene expression. HCMV encodes four proteins that modulate the Rb-E2F pathway: pp71, IE1, IE2, and the focus of this application, UL97. Because HCMV is associated with proliferative diseases and encodes multiple proteins that modulate the Rb-E2F pathway, we hypothesize that the Rb-E2F pathway plays a critical role in HCMV replication and pathogenesis. Here we propose to explore the roles of the Rb, E2F, and UL97 proteins during HCMV infection. UL97 is a member of a family of conserved herpesvirus protein kinases (CHPKs) that directly phosphorylates the Rb protein and inactivates it, leading to the induction of cellular E2F-responsive genes. We hypothesize that some of these E2F-responsive gene products (the NBEs) are responsible for the UL97-mediated stimulation of viral DNA replication. We further speculate that other E2F-responsive gene products induced by UL97 (secreted wound healing and angiogenesis factors) may in turn be partially responsible for proliferative pathologies associated with HCMV infection, such as restenosis, TVS, and GBMs. The long-term goal of this project is to determine how Rb inactivation by UL97 and other HCMV proteins impacts cell cycle progression, HCMV replication, and viral pathogenesis in both cell autonomous and non-cell-autonomous manners, and to use this information to design therapies to treat proliferative diseases associated with HCMV infection. PHS 398/2590 (Rev. 05/01) Page 1 Continuation Format Page
PUBLIC HEALTH RELEVANCE: Some viruses cause cancer, a disease of uncontrolled cellular growth. Human cytomegalovirus (HCMV) infects almost everyone, causes severe disease especially in newborn infants and transplant patients, and may play a role in many different types of cancer. We are studying how HCMV causes cells to grow in the hopes of finding drugs to stop that process, and that could be used as anti-viral and anti-cancer treatments.
描述(由申请人提供):人巨细胞病毒(HCMV)是一种普遍存在且重要的病原体,可刺激细胞周期进程。 HCMV 是心血管疾病的辅助因子,具有显着的增殖成分,例如冠状动脉再狭窄和移植血管硬化 (TVS),并且可能在某些类型的癌症中发挥作用,尤其是恶性神经胶质瘤 (GBM)。细胞增殖和转化受肿瘤抑制因子视网膜母细胞瘤家族(Rb、p107 和 p130)的调节。 Rb 蛋白与 E2F 转录因子家族一起调节 DNA 复制所需的细胞基因的表达,例如从头途径的核苷酸生物合成酶 (NBE),以及参与伤口愈合和血管生成的分泌因子。当低磷酸化形式的 Rb 蛋白与 E2F 蛋白结合时,E2F 响应基因的表达受到抑制。低磷酸化 Rb 蛋白的降解或其过度磷酸化会破坏其与 E2F 的复合物,从而允许游离的 E2F 激活基因表达。 HCMV 编码四种调节 Rb-E2F 途径的蛋白质:pp71、IE1、IE2,以及本申请的重点 UL97。由于 HCMV 与增殖性疾病相关并编码多种调节 Rb-E2F 途径的蛋白质,因此我们假设 Rb-E2F 途径在 HCMV 复制和发病机制中发挥关键作用。在这里,我们建议探讨 Rb、E2F 和 UL97 蛋白在 HCMV 感染过程中的作用。 UL97 是保守疱疹病毒蛋白激酶 (CHPK) 家族的成员,可直接磷酸化 Rb 蛋白并使其失活,从而诱导细胞 E2F 响应基因。我们假设其中一些 E2F 响应基因产物 (NBE) 负责 UL97 介导的病毒 DNA 复制刺激。我们进一步推测,由 UL97(分泌性伤口愈合和血管生成因子)诱导的其他 E2F 反应基因产物可能反过来部分负责与 HCMV 感染相关的增殖病理学,例如再狭窄、TVS 和 GBM。该项目的长期目标是确定 UL97 和其他 HCMV 蛋白使 Rb 失活如何以细胞自主和非细胞自主方式影响细胞周期进程、HCMV 复制和病毒发病机制,并利用这些信息来设计治疗与 HCMV 感染相关的增殖性疾病的疗法。 PHS 398/2590 (Rev. 05/01) 第 1 页 继续格式页
公共卫生相关性:一些病毒会导致癌症,这是一种细胞生长不受控制的疾病。人类巨细胞病毒 (HCMV) 几乎感染所有人,引起严重疾病,尤其是新生儿和移植患者,并且可能在许多不同类型的癌症中发挥作用。我们正在研究 HCMV 如何导致细胞生长,希望找到阻止该过程的药物,并可用于抗病毒和抗癌治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT F KALEJTA其他文献
ROBERT F KALEJTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT F KALEJTA', 18)}}的其他基金
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization
破译 HCMV 皮膜传递的 pp71 亚细胞定位的细胞类型特异性控制
- 批准号:
10176409 - 财政年份:2020
- 资助金额:
$ 35.6万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
10370328 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9894713 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Evading innate immunity during human cytomegalovirus latency
在人类巨细胞病毒潜伏期逃避先天免疫
- 批准号:
9919503 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
9447725 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Evading innate immunity during human cytomegalovirus latency
在人类巨细胞病毒潜伏期逃避先天免疫
- 批准号:
10392335 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Transcriptional Control of Human Cytomegalovirus Latency
人类巨细胞病毒潜伏期的转录控制
- 批准号:
10132969 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
7984157 - 财政年份:2010
- 资助金额:
$ 35.6万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
8651405 - 财政年份:2010
- 资助金额:
$ 35.6万 - 项目类别:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
人巨细胞病毒感染细胞中的视网膜母细胞瘤 (Rb) 蛋白途径
- 批准号:
8066409 - 财政年份:2010
- 资助金额:
$ 35.6万 - 项目类别:
相似国自然基金
整合转录因子上下游调控信息的心血管通路异常区域识别方法研究
- 批准号:62302206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“免疫-血管-半月板再生”机制构建负泊松比和结构/细胞双重梯度仿生不同区域的组织工程半月板
- 批准号:82372490
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
数据驱动的心血管疾病区域协同医疗服务研究
- 批准号:72301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高温与臭氧复合暴露对我国心脑血管疾病寿命损失年的区域分异影响及未来风险预估研究
- 批准号:42305191
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
星形胶质细胞微区域钙活动对缺血性卒中后神经血管耦合的调节作用及药物靶标研究
- 批准号:82230115
- 批准年份:2022
- 资助金额:261 万元
- 项目类别:重点项目
相似海外基金
Extracellular Vesicle Therapy for Diabetic Retinopathy
细胞外囊泡治疗糖尿病视网膜病变
- 批准号:
10723000 - 财政年份:2023
- 资助金额:
$ 35.6万 - 项目类别:
Per- and poly-fluoroalkyl substances (PFAS) in pregnancy vascular and placental dysfunction
全氟烷基物质和多氟烷基物质 (PFAS) 与妊娠血管和胎盘功能障碍的关系
- 批准号:
10593111 - 财政年份:2022
- 资助金额:
$ 35.6万 - 项目类别:
Per- and poly-fluoroalkyl substances (PFAS) in pregnancy vascular and placental dysfunction
全氟烷基物质和多氟烷基物质 (PFAS) 与妊娠血管和胎盘功能障碍的关系
- 批准号:
10452310 - 财政年份:2022
- 资助金额:
$ 35.6万 - 项目类别: